Michael L Savage
Overview
Explore the profile of Michael L Savage including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Savage M, Hay K, Vollbon W, Murdoch D, Hammett C, Crowhurst J, et al.
Catheter Cardiovasc Interv
. 2024 Sep;
104(5):934-944.
PMID: 39228191
Background: Historically, differences in timely reperfusion and outcomes have been described in females who suffer ST-segment elevation myocardial infarction (STEMI). However, there have been improvements in the treatment of STEMI...
2.
Crowhurst J, Tse J, Mirjalili N, Savage M, Raffel O, Gaikwad N, et al.
Am J Cardiol
. 2023 Aug;
203:429-435.
PMID: 37536045
Continuous exposure to low-level scattered radiation to staff performing cardiac angiography and intervention is of concern. A novel shielding solution (NSS) (Rampart IC M1128) has the potential to provide greater...
3.
Savage M, Hay K, Vollbon W, Doan T, Murdoch D, Hammett C, et al.
J Am Heart Assoc
. 2023 Jul;
12(14):e029346.
PMID: 37449585
Background Prehospital activation of the cardiac catheter laboratory is associated with significant improvements in ST-segment-elevation myocardial infarction (STEMI) performance measures. However, there are equivocal data, particularly within Australia, regarding its...
4.
Savage M, Hay K, Anderson B, Scalia G, Burstow D, Murdoch D, et al.
Crit Care Res Pract
. 2022 Nov;
2022:8343785.
PMID: 36405398
Background: When compared to left ventricular ejection fraction (LVEF), previous studies have suggested the superiority of wall motion score index (WMSI) in predicting cardiac events in patients who have suffered...
5.
Savage M, Hay K, Murdoch D, Walters D, Denman R, Ranasinghe I, et al.
Catheter Cardiovasc Interv
. 2022 Aug;
100(4):520-529.
PMID: 35971748
Objectives: We assessed sex differences in treatment and outcomes in ST-segment elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PCI). Background: Historically, delays to timely reperfusion and...
6.
Savage M, Hay K, Murdoch D, Doan T, Bosley E, Walters D, et al.
Heart Lung Circ
. 2022 Mar;
31(7):974-984.
PMID: 35227611
Introduction: Pre-hospital activation and direct cardiac catheterisation laboratory (CCL) transfer of ST segment elevation myocardial infarction (STEMI) has previously been shown to improve door-to-balloon (DTB) times yet there is limited...
7.
Yates D, Savage M, Walters D, Raffel O
Heart Lung Circ
. 2015 Nov;
25(4):342-51.
PMID: 26530435
Background: The efficacy of second-generation drug-eluting stents (DES) in treating in-stent restenosis (ISR) compared to first-generation DES and non-DES treatment methods in real-world cohorts has not yet been adequately addressed....
8.
Savage M, Poon K, Johnston E, Raffel O, Incani A, Bryant J, et al.
Heart Lung Circ
. 2014 Jan;
23(5):435-43.
PMID: 24388497
Background: Mortality in ST elevation myocardial infarction (STEMI) is strongly predicted by the time from first medical contact to reperfusion. The aim of this study was to examine the impact...